Leerink Partners Maintains Tourmaline Bio(TRML.US) With Buy Rating, Maintains Target Price $49

Futu NewsDec 12 15:32 · Ratings

Cantor Fitzgerald Reiterates Overweight on Tourmaline Bio, Maintains $25 Price Target

BenzingaDec 12 00:24 · Ratings

Truist Financial Maintains Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsDec 11 21:31 · Ratings

H.C. Wainwright Maintains Tourmaline Bio(TRML.US) With Buy Rating, Maintains Target Price $49

Futu NewsDec 11 19:31 · Ratings

Strategic Developments in Tourmaline Bio's Cardiovascular Programs Drive Buy Rating

TipRanksDec 11 19:26 · Ratings

Tourmaline Bio Unveils Clinical Progress and New Indication

TipRanksDec 10 22:01